ArticleFood science & nutrition2026
Epigallocatechin Gallate From Tea Delays Oocyte Aging After Ovulation in Mice.
Article in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In clinic, once the ovulated oocytes cannot be fertilized timely, they begin to undergo post-ovulatory aging, which impacts the embryo development and offspring health. Until now, there are no better methods to delay post-ovulatory oocyte aging. Epigallocatechin gallate (EGCG) is the most abundant bioactive component of tea polyphenols that are beneficial for alleviating the deleterious influence of environmental factors on oocyte quality. In the present study, we examined the role of EGCG in delaying oocyte aging after ovulation in vitro. Ovulated oocytes were treated with EGCG at different concentrations, and the fragmentation rate, induced by aging, was significantly reduced by EGCG at 50 μM in vitro. To further elucidate the influence of EGCG on the quality of post-ovulatory aged oocytes, we examined the spindle morphology of aged oocytes. The results showed that EGCG significantly decreased the abnormal rate of spindle morphology in post-ovulatory aged oocytes. The high level of reactive oxygen species (ROS) and mitochondrial dysfunction in post-ovulatory aged oocytes were also improved by EGCG, which might be a reason for the reduced apoptosis. The reduced sperm binding capacity of aged oocytes was increased by the addition of EGCG. These suggest that EGCG can improve the quality of post-ovulatory aged oocytes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.